The Steering Group agreed the terms of reference for the review and, in consultation with the UK Human
Geography community, appointed an International Panel of leading international experts, chaired
by Professor David Ley, University of British Columbia, Canada The International Panel visited the UK for one week in May 2012 and met with about 150 stakeholders in UK Human
Geography Prior to its UK visit, the Panel was provided with a range of background data including: Overviews of research
trends and outputs since 2000 completed
by representatives of the nine Human
Geography sub-disciplines Two - page assessments
by Heads of UK
Geography Departments of strengths, weaknesses, overall health, and future opportunities and challenges to Human
Geography in the UK (15 submissions were received) A statistical profile of UK Human
Geography: Briefing Document: Statistical Overview and Commentary
by Paul Wakeling (2012) Bibliometric Data for the ESRC International Benchmarking Review of Human
Geography by Thomson Reuters (2012) A Short Introduction to UK Research Funding Policy
by David Mills (2012) Survey of Users of Human
Geography Research
by Steve Johnson, David Gibbs and Ian Mills (2012).
The study, conducted jointly
by researchers at Harvard and UT Southwestern Medical Center, is the first to look at state - level
trends in child fatalities involving motor vehicle crashes, and to account for differences in
geography and state laws and regulations.
However I did look at what would happen after that in relative, rather than absolute time,
by featuring not only changes in
geography, but in chapter
by chapter fashion looking at
trends in human population, agriculture, coastal city infrastructure (all those buried wires!)
The S&P Healthcare Claims Indices track healthcare cost and utilization
trends across various commercial lines of business
by geography (census division, region, state, and metropolitan area), healthcare type (medical, hospital, inpatient, outpatient, professional services, drug, generic drug, and brand drug), as well as
by incurred period.